Back to IMRX

UBS Group AG → IMRX

UBS Group AG IMRX Position History

Immuneering Corporation • Healthcare

Quarters held
14
Latest value
$81K
Q3 2026
Peak value
$2M
First seen
Q3 2025

Dollar value over time

Show data table
PeriodPosition value
Q3 2025$14K
Q3 2025$821K
Q3 2025$49K
Q4 2025$976K
Q4 2025$266K
Q4 2025$9K
Q1 2026$1.8M
Q1 2026$214K
Q1 2026$8K
Q2 2026$2M
Q2 2026$241K
Q3 2026$1.1M
Q3 2026$232K
Q3 2026$81K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$81K19.9K——
Q3 2026$232K56.6K——
Q3 2026$1.1M274.2K——
Q2 2026$241K48.2K——
Q2 2026$2M400.7K——
Q1 2026$8K1.5K——
Q1 2026$214K40.5K——
Q1 2026$1.8M334.3K——
Q4 2025$9K1.4K——
Q4 2025$266K40.5K——
Q4 2025$976K148.4K——
Q3 2025$49K7.1K——
Q3 2025$821K117.4K——
Q3 2025$14K2.0K——

Other funds holding IMRX

$37.6M
$37.6M
$30.1M
$27.9M
$25.5M
$23.2M
$20.8M

Other UBS Group AG positions

MSFT

MICROSOFT CORP

$8.1B
AAPL

APPLE INC

$7.8B
NVDA

NVIDIA CORPORATION

$7.8B
AAPL

APPLE INC

$7.7B
NVDA

NVIDIA CORPORATION

$7.7B
MSFT

MICROSOFT CORP

$7.6B
MSFT

MICROSOFT CORP

$7.4B
NVDA

NVIDIA CORPORATION

$7.3B